No takes yet. Share an insight, caveat, or question.
The study evaluates how blood processing affects CHI3L1 levels in MS, indicating standardized guidelines for its use as a biomarker.
Comabella et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: